•
Sep 30, 2019

Leap Therapeutics Q3 2019 Earnings Report

EPS
-$3.3
Previous year: -$5.5
-40.0%
Cash and Equivalents
$10.1M
Previous year: $23.2M
-56.7%
Free Cash Flow
-$6.96M
Total Assets
$14.1M
Previous year: $27.1M
-47.9%

Leap Therapeutics

Leap Therapeutics